iohexol has been researched along with Tumour Lysis Syndrome in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yun, S | 1 |
| Vincelette, ND | 1 |
| Phan, T | 1 |
| Anwer, F | 1 |
1 other study available for iohexol and Tumour Lysis Syndrome
| Article | Year |
|---|---|
Spontaneous tumour lysis syndrome associated with contrast dye iohexol use in mantle cell lymphoma.
Topics: Aged; Biopsy; Contrast Media; Diagnosis, Differential; Humans; Iohexol; Lymphoma, Mantle-Cell; Male; | 2014 |